Melissa Vos, PhD
Research Group Leader
Name: Melissa Vos
Date of Birth: January 22st, 1985
Place of Birth: Herentals, Belgium
Position/Title: Research Group Leader, PhD, at the Institute of Neurogenetics
Address: Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
Phone: +49-451-3101 8203
2003 – 2007: Biomedical sciences (Masters in Biomedical Science); KU Leuven, Belgium graduated with Distinction, Advisor: Dr. Marc Van Ranst (Characterization of novel Papillomaviruses)
2009 – 2012: Ph.D. in Biomedical sciences; KU Leuven, Center for Human Genetics, VIB Center for the Biology of Disease, Leuven, Belgium, Advisor: Patrik Verstreken
2017- current: Group leader ‘Drosophila models of neurodegeneration’ at the Institute of Neurogenetics
06/2012: Author of the month; Award from the Center for Human genetics KU Leuven, Belgium
2013: Runner-up in the Larry Sandler award for best dissertation in the Drosophila field, GSA
09/2014: Prize of the Research Council (7500€) to stimulare young postdoctoral researchers, KU Leuven, Belgium
09/2014: Special acknowledgement baron Simonart foundation to encourage research in clinical pharmacology, Belgium
2009-2012: Predoctoral Fellowship; IWT Vlaanderen, Belgium; Fellowship obtained after personal defense of the project
2013: Postdoctoral Fellowship; KU Leuven, Belgium
2014-2016: Post-doctoral fellowship; FWO, Belgium
10/2013: Travel grant (400€); GEO-PD meeting, Lubeck, Germany
12/2013: Travel grant; FWO, mitochondrial Keystone meeting, Santa Fe, USA
2014: Junior Mobility award for a stay abroad, KU Leuven, Belgium
2014: Award for a long stay abroad, FWO, Belgium
2015: Postdoctoral felloyship; EMBO
The Implication of Lipids in Parkinson’s Disease Pathogenesis
Principal Investigator: Melissa Vos
Funding Agency: University of Lübeck, Germany (Intramural funding)
Funding Period: 01.01.2016-31.12.2017
Amount: € 75,000
Elucidating the Interaction between Mitochondria and Lipids in Parkinson’s Disease
Principal Investigator: Melissa Vos
Funding Agency: Else-Kröner-Fresenius Stiftung
Funding Period: 01.09.2017-31.08.2020
Amount: € 294,030
Advanced Biology of the Cell/Neuron
Drosophila as animal model in the study of neurodegeneration
- Vos M. Vitamin K2 is a mitochondrial electron carrier that rescues Pink1 deficiency. GEO-PD meeting, Lübeck, Germany, October 2013.
- Vos M. Vitamin K2 as a potential novel therapeutic strategy in Parkinson’s disease. Ophtalmology Conference, OMICS, Baltimore, USA, June 2014.
- Vos M. Mitochondrial dysfunction in Parkinson’s disease and role of vitamin K2. Neurology seminar series, Université Catholique de Louvain, Brussels, Belgium, January 2015
- Dulovic-Mahlow M, Trinh J, Kandaswamy KK, Braathen GJ, Di Donato N, Rahikkala E, Beblo S, Werber M, Krajka V, Busk ØL, Baumann H, Al-Sannaa NA, Hinrichs F, Affan R, Navot N, Al Balwi MA, Oprea G, Holla ØL, Weiss MER, Jamra RA, Kahlert AK, Kishore S, Tveten K, Vos M, Rolfs A, Lohmann K. De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders. Am J Hum Genet 2019;1:213-220.
- Vos M, Geens A, Böhm C, Deaulmerie L, Swerts J, Rossi M, Craessaerts K, Leites EP, Seibler P, Rakovic A, Lohnau T, De Strooper B, Fendt SM, Morais VA, Klein C, Verstreken P. Cardiolipin promotes electron transport between ubiquinone and complex I to rescue PINK1 deficiency. J Cell Biol 2017;3:695-708.
- Vos M, Verstreken P, Klein C. Stimulation of electron transport as potential novel therapy in Parkinson’s disease with mitochondrial dysfunction. Biochem Soc Trans 2015;2:275-279.